Loading...
A New FXR Ligand Chemotype with Agonist/Antagonist Switch
[Image: see text] Therapeutic modulation of the bile acid-sensing transcription factor farnesoid X receptor (FXR) is an appealing strategy to counteract hepatic and metabolic diseases. Despite the availability of several highly potent FXR agonists structural diversity of FXR modulators is limited, a...
Na minha lista:
| Udgivet i: | ACS Med Chem Lett |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Chemical
Society
2021
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883470/ https://ncbi.nlm.nih.gov/pubmed/33603974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.0c00647 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|